Correction to: Cell research https://doi.org/10.1038/s41422-020-0277-x, published online 23 January 2020
We apologize for a mistake in Fig. 2 that we just identified in our manuscript published online on January 23, 2020. On the top right of the figure the crosses and question marks do not correspond to the correct molecules. CTLA-4 and PD-1 should have the cross and the other 3 receptors the question marks. The correct version of Fig. 2 is shown below. The correction does not affect the description and conclusion of this review.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41422-020-0277-x.
Rights and permissions
About this article
Cite this article
Schnell, A., Bod, L., Madi, A. et al. Author Correction: The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity. Cell Res 30, 366 (2020). https://doi.org/10.1038/s41422-020-0285-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41422-020-0285-x
This article is cited by
-
Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer
Cell Death & Differentiation (2023)
-
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
Journal of Nanobiotechnology (2022)